Zelira Therapeutics Stock (OTC:ZLDAF), Quotes and News Summary

Q: What sector and industry does Zelira Therapeutics (ZLDAF) operate in?

Zelira Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.

Zelira Therapeutics Stock (OTC: ZLDAF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 250.000
Day Range	- - -
52 Wk Range	0.470 - 1.650
Market Cap	$5.447M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1.09

Recent News

This Cannabis-Based Drug Has Outperformed Pfizer's Lyrica In Clinical Trials: A New Dawn For Diabetic Nerve Pain Management?

Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a leading player in cannabinoid medicine research, has successfully demonstrated that its proprietary drug for diabetic nerve pain, ZLT-L-007, surpasses the efficacy of Pfizer Inc. (NYSE:

Javier Hasse

Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment

Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a developer of cannabinoid-based medicines, will conduct FDA Phase 2 and Phase 3 clinical trials for its HOPE-1 treatment of Autism Spectrum Disorder (ASD).

Joana Scopel

A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond

Less than 30 years after Israel became the first nation in the world to allow its citizens to use cannabis for medical purposes, the medical and adult-use cannabis markets have spread across the globe at a dizzying rate.

Javier Hasse

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-base...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Zelira Therapeutics (ZLDAF) stock?

You can purchase shares of Zelira Therapeutics (OTCQB: ZLDAF) through any online brokerage.

View our list of the best stock brokerages.

Who are Zelira Therapeutics's (ZLDAF) competitors?

There are no as such competitors for Zelira Therapeutics.

What is the target price for Zelira Therapeutics (ZLDAF) stock?

There is no analysis for Zelira Therapeutics.

Current Stock Price for Zelira Therapeutics (ZLDAF)?

The stock price for Zelira Therapeutics (OTCQB: ZLDAF) is $0.48 last updated April 4, 2024 at 1:07 PM EDT.

Does Zelira Therapeutics (ZLDAF) pay a dividend?

There are no upcoming dividends for Zelira Therapeutics.

When is Zelira Therapeutics (OTCQB:ZLDAF) reporting earnings?

Zelira Therapeutics does not have any upcoming earnings scheduled.

Is Zelira Therapeutics (ZLDAF) going to split?

There is no upcoming split for Zelira Therapeutics.

What sector and industry does Zelira Therapeutics (ZLDAF) operate in?

Zelira Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.